Synergy of itraconazole with macrophages in killing Blastomyces dermatitidis
- 1 November 1992
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 36 (11) , 2487-2492
- https://doi.org/10.1128/aac.36.11.2487
Abstract
We examined in vitro interaction between the azole antifungal agents itraconazole and ketoconazole and macrophages and their activities against Blastomyces dermatitidis. Fungistatic and fungicidal concentrations for B. dermatitidis in vitro were assessed in a microculture system in which fungistasis was measured as inhibition of multiplication and fungicidal activity was measured as reduction of inoculum CFU. Resident peritoneal murine macrophages, which surround but do not phagocytize the fungus, were not fungicidal for B. dermatitidis isolates but were fungistatic for some isolates studied. Synergy was demonstrated when fungistatic concentrations (e.g., 0.01 micrograms/ml) of itraconazole, which limited growth 55% compared with that of controls, were cocultured with macrophages; this resulted in fungicidal activity (85% killing) against B. dermatitidis (ATCC 26199) in 72-h assays. This synergy could occur even if itraconazole was added after the macrophages had surrounded the fungus. Ketoconazole at fungistatic concentrations did not act synergistically with macrophages to kill B. dermatitidis. Lymph node lymphocytes could not substitute for macrophages in synergy with itraconazole to kill B. dermatitidis. When B. dermatitidis was separated by a filter from macrophages in Transwell cultures, fungicidal synergy with itraconazole was less efficient. Pretreatment of B. dermatitidis with itraconazole for 24 h did not render the fungus susceptible to killing by macrophages in the absence of itraconazole, whereas pretreatment of nonfungistatic macrophages with itraconazole rendered them fungistatic in a dose-dependent manner. Three other isolates were killed by otherwise fungistatic concentrations of itraconazole when the isolates were cocultured with macrophages. These findings indicate that one basis for the efficacy of itraconazole versus ketoconazole in treating blastomycosis could be synergy of a fungistatic concentration of itraconazole with macrophages in killing of B. dermatitidis.Keywords
This publication has 18 references indexed in Scilit:
- The Effect of Ketoconazole on the Phagocytosis and Intracellular Killing of Candida albicans by Polymorphonuclear GranulocytesMycoses, 2009
- Efficacy of Itraconazole in Blastomycosis in a Murine Model and Comparison with KetoconazoleMycoses, 1989
- Effects of azole antifungals in vitro on host/parasite interactions relevant to candida infectionsJournal of Antimicrobial Chemotherapy, 1988
- Effects of Antifungal Agents and Interferon on Macrophage Cytotoxicity for Fungi and Tumor CellsThe Journal of Infectious Diseases, 1987
- Initial Experience in Therapy for Progressive Mycoses with Itraconazole, the First Clinically Studied TriazoleClinical Infectious Diseases, 1987
- Sensitivity testing with ketoconazole in an assay containingCandida albicans, human polymorphonuclear leukocytes and serumEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- In-vitro effect of itraconazole, ketoconazole and amphotericin B on the phagocytic and candidacidal function of human neutrophilsJournal of Antimicrobial Chemotherapy, 1986
- Isolation ofBlastomyces dermatitidisin Soil Associated with a Large Outbreak of Blastomycosis in WisconsinNew England Journal of Medicine, 1986
- Modification of polymorphonuclear leucocyte function by imidazolesInternational Journal of Immunopharmacology, 1984
- The effects of ketoconzole on cellular and humoral immune functionsJournal of Antimicrobial Chemotherapy, 1983